Nabriva Therapeutics plc Nabriva Therapeutics plc

Nabriva Therapeutics plc

NBRV

Rang în acțiuni #39899
Nabriva Therapeutics plc is a biopharmaceutical company focused on the... Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.
Preț acțiune
$0.63
Ultima sincronizare: 2023-08-29
Capitalizare de piață
$284.20K
Schimbare (1 zi)
-21.25%
Schimbare (1 an)
629,900.02%
Țară
IE
Tranzacționează Nabriva Therapeutics plc (NBRV)

Categorie

Healthcare
Prețul NBRV cu capitalizarea de piață a B
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
$0.63
Capitalizarea de piață a Nabriva Therapeutics plc(NBRV)
Capitalizare de piață: $284.20K
În anul October 2026, Nabriva Therapeutics plc are o capitalizare de piață de $284.20K. Acest lucru face ca Nabriva Therapeutics plc să fie a 39899th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Nabriva Therapeutics plc din 2023 până în 2026
NBRV în comparație cu top 5 cele mai populare stocks
Prețul pentru NBRV Activul B Capitalizarea de piață a B Rezultate
Nabriva Therapeutics plc Nabriva Therapeutics plc
$1,599,703 $323.00
$5.167T +1,599,702,786,277.71%
Nabriva Therapeutics plc Nabriva Therapeutics plc
$1,552,563 $323.00
$5.015T +1,552,563,207,547.06%
Nabriva Therapeutics plc Nabriva Therapeutics plc
$1,271,951 $323.00
$4.108T +1,271,951,153,813.31%
Nabriva Therapeutics plc Nabriva Therapeutics plc
$1,208,020 $323.00
$3.902T +1,208,019,739,373.68%
Nabriva Therapeutics plc Nabriva Therapeutics plc
$832,649 $323.00
$2.689T +832,648,929,311.77%